No Detail Found!

Frequency of Prothrombin Gene Mutation in Venous Thromboembolism in Northern Pakistan.

Author(s)
Zunera Sajjad Armed Forces Institute of Pathology (AFIP), National University of Medical Sciences (NUMS), Rawalpindi, Pakistan
Saleem Ahmed Khan Army Medical College/ National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Hamid Saeed Malik Armed Forces Institute of Pathology (AFIP), National University of Medical Sciences (NUMS), Rawalpindi, Pakistan
Chaudry Altaf Armed Forces Institute of Pathology (AFIP), National University of Medical Sciences (NUMS), Rawalpindi, Pakistan
Nabeela Khan Armed Forces Institute of Pathology (AFIP), National University of Medical Sciences (NUMS), Rawalpindi, Pakistan
Ayesha Khurshid Armed Forces Institute of Pathology (AFIP), National University of Medical Sciences (NUMS), Rawalpindi, Pakistan
Abstract
Objective: To determine the frequency of prothrombin gene mutation in venous thromboembolism in our population. Study Design: Cross sectional study. Place and Duration of Study: Department of Haematology, Armed Forces Institute of Pathology Rawalpindi, from Jun 2015 to Dec 2016. Material and Methods: This cross sectional study was conducted in the Department of Haematology, Armed Forces Institute of Pathology Rawalpindi from Jun 2015 to Dec 2016. This study involved patients of both genders aged between 15-45 years who presented with one or more episodes of deep vein thrombosis or pulmonary embolism. Outcome variable was frequency of prothrombin gene mutation which was assessed by PCR of genomic DNA. Results: A total of 96 newly diagnosed patients of venous thromboembolism were analyzed. Out of these, 79 patients had deep vein thrombosis and 17 had pulmonary embolism. Prothrombin gene mutation was seen in 4 (4.2%) patients. The frequency of prothrombin gene mutation was significantly higher among patients with pulmonary embolism (p=0.002) and recurrent episodes (p=0.046). Conclusion: The frequency of prothrombin gene mutation was found to be 4.2% in the present study. It was significantly higher in patients with pulmonary embolism and recurrent thrombosis.
Publication Details
Page(s) 4-7
DOI DOI not available
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 68, Issue: 1, Year: 2018

Request the full text from PASTIC

References
YilmazS,GunaydinS., 2015.Inherited risk factors in low-risk venous thromboembolism in patients under 45 years. ",Interact Cardiovasc Thorac Sur 20 21 -3
KupeliE,VerdiH,ŞimşekA,AtaçBF,EyüboğluFO, 2011.Genetic mutations in Turkish population with pulmonary embolism and deep venous thrombosis,Clin Appl Thromb Hemost 17 E87 -94
MargaglioneM,GrandoneE., 2011.Population genetics of venous thromboembolism. A narrative review,Thromb Haemost 105 221 -31
RaskobGE,SilversteinR,BratzlerDW,HeitJA,WhiteRH, 2010.Surveillance for deep vein thrombosis and pulmonary embolism: Recommendations from a national workshop,Am J Prev Med 38 S502 -9
ZakaiNA,McClureLA, 2011.Racial differences in venous thromboembolism,J Thromb Haemost 9 1877 -82
HosseeiniS,KalantariE,DorgalalehA,RozeiA,JafariM,NaderiM, 2013.Molecular Analysis Of Patients With Deep Venous Thrombosis,Blood 122 4799 -
JadaonMM, 2011.Epidemiology of prothrombin G20210A mutation in the mediterranean region,Mediterr J Hematol Infect Dis 3 467 -92
MiyawakiY,SuzukiA,FujitaJ,MakiA,OkuyamaE,MurataM, 2012.Thrombosis from a prothrombin mutation conveying antithrombin resistance,N Engl J Med 366 2390 -6
MiljićP,HeylenE,WillemseJ,DjordjevićV,RadojkovićD,ColovićM, 2010.Thrombin activatable fibrinolysis inhibitor (TAFI): A molecular link between coagulation and fibrinolysis Srp Arh Celok Lek, 138 74 -8
AlvarezSI,OlleroEB,LlinaresSanjuanFM,MartínezFL, 2014.Calvo Martín MT. A deep vein thrombosis caused by 20209 C>T mutation in homozygosis of the prothrombin gene in a Caucasian patient,Biochem Med 24 159 -66
NaqviSE,HaseenMA,BegMH,AliE,KhanT, 2016.,Deep Vein Thrombosis: An Experience of 25 Years from North India. Indian J Vasc Endovasc Surg 3 2 -6
SaeedA,Sumreen, 2015.To determine the frequency of Factor V Leiden in cases of Deep Vein Thrombosis and Healthy controls,Pak J Med Sci 31 1219 -22
AliNS,NawazA,JunaidM,KaziM,AkhtarS, 2015.Venous thromboembolism - Incidence of deep venous thrombosis and pulmonary embolism in patients with head and neck cancer: A tertiary care experience in Pakistan,Int Arch Otorhinolaryngol 19 200 -4
ShahS,BhalodiaR,PatelK, 2015.Prevalence of deep vein thrombosis with lower limb trauma patients,IntJ Biomed Adv Res 6 9 -15
KhaladkarSM,ThakkarDK,ShindeK,ThakkarDK,ShrotriH,KulkarniVM, 2014.Deep vein thrombosis of the lower limbs: A retrospective analysis of doppler ultrasound findings,J Med DYP Uni 7 612 -19
BalluS,NyatiM,KajjaI., 2013.Deep venous thrombosis in patients with acute traumatic spinal cord injury: prevalence and patterns in a major teaching hospital in Uganda,East Afr Orthop J 7 36 -43
MilesJS,MiletichJP,GoldhaberSZ,HennekensCH,RidkerPM, 2001.G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism,J Am Coll Cardiol 37 215 -8
AttiaFM,MikhailidisDP,ReffatSA, 2009.Prothrombin Gene G20210A mutation in acute deep venous thrombosis patients with poor response to warfarin therapy,Open Cardiovasc Med J 3 147 -51
DentaliF,AgenoW,BozzatoS,MalatoA,GianniM,SquizzatoA, 2012.Role of factor V Leiden or G20210A prothrombin mutation in patients with symptomatic pulmonary embolism and deep vein hrombosis: A meta-analysis of the literature,J Thromb Haemost 10 732 -7
MartinelliI,BattaglioliT,RazzariC,MannucciPM, 2007.Type and location of venous thromboembolism in patients with factor V Leiden or prothrombin G20210A and in those with no thrombophilia,J Thromb Haemost 5 98 -101
0

Citations

0

Downloads

67

Views